Liquidia CORP Form 4 insider transactions

NASDAQ
Liquidia Corp's Chief Accounting Officer, Dana Boyle, sold 1,073 shares of common stock at $22.93 per share to cover tax liabilities from restricted stock unit settlements.
NASDAQ
Liquidia Corp's General Counsel, Russell Schundler, reported the conversion of performance stock units and a subsequent sale of shares to cover tax obligations.
NASDAQ
Liquidia Corp's CFO and COO, Michael Kaseta, reported the acquisition of common stock from PSU conversion and subsequent sale of shares to cover tax liabilities.
NASDAQ
Liquidia Corp's Chief Commercial Officer, Scott Moomaw, sold 4,900 shares for $23.41 each to cover taxes after vesting of performance stock units.
NASDAQ
Liquidia Corp's Chief Medical Officer, Rajeev Saggar, sold 5,327 shares of common stock at $23.41 to cover tax liabilities from vested equity awards.
NASDAQ
Liquidia Corp's Chief Accounting Officer, Dana Boyle, sold 1,238 shares of common stock at $23.41 per share to cover tax liabilities from restricted stock unit settlements.
NASDAQ
Liquidia Corp CEO Roger Jeffs filed a Form 4 detailing future equity award vesting and a pre-planned stock sale to cover tax obligations.
NASDAQ
Liquidia Corp's Chief Business Officer, Jason Adair, sold 3,670 shares of common stock to cover tax liabilities related to vested restricted and performance stock units.
NASDAQ
Liquidia Corp's Chief Human Resource Officer, Sarah Krepp, sold 1,691 shares of common stock at $23.41 per share to cover tax liabilities from restricted stock unit settlements.
NASDAQ
Liquidia Corp. Director Stephen M. Bloch filed an amended Form 4 to correct an administrative error, disclosing 2,917,169 indirectly held common shares.
NASDAQ
Liquidia Corp Director Raman Singh exercised stock options and subsequently sold 45,524 shares of common stock on September 15, 2025.
NASDAQ
Liquidia Corp Director Raman Singh reported the sale of 7,500 common stock shares at $29.42 each, reducing his direct beneficial ownership to 31,255 shares.
NASDAQ
Liquidia Corp's Chief Accounting Officer, Dana Boyle, sold 296 shares of common stock to cover tax liabilities from restricted stock unit settlements.
NASDAQ
Liquidia Corp's Chief Commercial Officer, Scott Moomaw, sold a significant number of shares following the vesting of restricted stock units, primarily under pre-arranged trading plans.
NASDAQ
Liquidia Corp's General Counsel, Russell Schundler, reported the conversion of restricted stock units and a subsequent sale of common stock to cover tax obligations.
NASDAQ
Liquidia Corp's Chief Human Resource Officer, Sarah Krepp, sold 209 shares of common stock at $29.05 per share to cover tax liabilities from RSU settlement.
NASDAQ
Liquidia Corp's CFO and COO, Michael Kaseta, acquired common stock from RSU vesting and subsequently sold a portion to cover tax liabilities.
NASDAQ
Liquidia Corp Director Paul B. Manning sold 670,837 shares of common stock across multiple transactions in late August and early September 2025, totaling approximately $18.96 million.
NASDAQ
Liquidia Corp's Chief Business Officer, Jason Adair, reported multiple transactions including RSU conversions and sales under pre-arranged 10b5-1 plans.
NASDAQ
Liquidia Corporation's Chief Medical Officer, Rajeev Saggar, sold 20,000 shares of common stock for approximately $27.85 per share, executed under a pre-arranged 10b5-1 trading plan.
NASDAQ
Liquidia Corp Director Joanna Horobin sold 5,000 shares of common stock for $27.17 per share under a pre-arranged trading plan.
NASDAQ
Liquidia Corp's CFO and COO, Michael Kaseta, sold 20,000 shares of common stock for $26.1837 per share under a pre-arranged 10b5-1 trading plan.
NASDAQ
Liquidia Corp's CFO and COO, Michael Kaseta, sold 30,000 shares of common stock for approximately $20.00 per share under a pre-arranged 10b5-1 plan.
NASDAQ
Liquidia Corporation's Chief Business Officer, Jason Adair, filed a Form 4 detailing a future sale of 454 shares of common stock to cover tax liabilities from restricted stock unit settlements.
NASDAQ
Liquidia Corporation's Chief Accounting Officer, Dana Boyle, sold 1,063 shares of common stock at $19.54 per share to cover tax obligations related to vested restricted stock units, as part of a pre-arranged 10b5-1 plan.
NASDAQ
Liquidia Corporation's Chief Medical Officer, Rajeev Saggar, sold 2,526 shares of common stock at $14.54 per share on July 21, 2025, to cover tax liabilities from restricted stock unit vesting.
NASDAQ
Liquidia Corp's General Counsel, Russell Schundler, reported the acquisition of common stock through PSU conversion and a subsequent sale of shares to cover tax obligations, all under a pre-arranged Rule 10b5-1 plan.
NASDAQ
Liquidia Corp's Chief Medical Officer, Rajeev Saggar, reported the conversion of performance stock units into common stock and a subsequent sale of shares to cover tax obligations, executed under a pre-arranged trading plan.
NASDAQ
Liquidia Corp's Chief Commercial Officer, Scott Moomaw, exercised performance stock units and subsequently sold a portion of common stock to cover tax obligations, as disclosed in a recent Form 4 filing.
NASDAQ
Liquidia Corp's Chief Human Resource Officer, Sarah Krepp, sold 2,673 shares of common stock at $14.28 per share on July 14, 2025, to cover tax obligations related to restricted stock unit settlements.